The Jackson Hole Lymphoid Malignancy Think Tank: Navigating the Evidence Gap 2027  conference hero image

The Jackson Hole Lymphoid Malignancy Think Tank: Navigating the Evidence Gap 2027

Start Date: End Date:
Register for Conference

Official conference page for The Jackson Hole Lymphoid Malignancy Think Tank: Navigating the Evidence Gap 2027 . https://binaytara.org/projects/conferences/the-jackson-hole-lymphoid-malignancy-think-tank-navigating-the-evidence-gap-2027

About The Jackson Hole Lymphoid Malignancy Think Tank: Navigating the Evidence Gap 2027

Conference
Conference attendees

Overview

Trusted by Thousands of Attendees
Across Our Events

Caron Jacobson
Tycel Phillips
10+

Faculty and committee

Conference program and agenda

Agenda

Day 1: Friday, April 23rd, 2027

All timings are in Mountain Time (MST, GMT-07:00) time.

07:00 AM - 07:55 AMBreakfast, Registration, and Exhibits
07:55 AM - 08:00 AMWelcome & Opening Remarks
08:00 AM - 09:45 AMSession 1: Precision Frontline Therapy Across CLL

08:00 AM - 08:15 AM

Molecular Risk Adaptation for CLL

08:15 AM - 08:30 AM

Frontline CLL Treatment Selection

08:30 AM - 08:45 AM

Frontline CLL Treatment Selection

08:45 AM - 09:00 AM

MRD in CLL: flow, NGS?

09:00 AM - 09:15 AM

ctDNA in CLL. Any role? – Ash A Alizadeh, MD, PhD

09:15 AM - 09:25 AM

Case

09:25 AM - 09:45 AM

Case-Based Panel Discussion

Panelist:

Ash A Alizadeh, MD, PhD

09:45 AM - 10:00 AMBreak & Exhibits
10:00 AM - 11:45 AMSession 2: What’s New in 2027? Frontline Therapy in Lymphoma

Session Chairs: Jason Westin ; Loretta J. Nastoupil

10:00 AM - 10:15 AM

Untreated Diffuse large B-cell lymphoma

10:15 AM - 10:30 AM

Untreated Follicular Lymphoma

10:30 AM - 10:45 AM

Untreated Mantle cell lymphoma

10:45 AM - 11:00 AM

Untreated Marginal zone lymphoma

11:00 AM - 11:15 AM

Untreated Hodgkin lymphoma – Anne LaCasce

11:15 AM - 11:25 AM

Case

11:25 AM - 11:45 AM

Case-Based Panel Discussion

Moderators:

Loretta J. Nastoupil ; Jason Westin

Panelist:

Anne LaCasce

11:45 AM - 01:00 PMLunch & Exhibits
01:00 PM - 02:45 PMSession 3: Precision Therapy in Relapsed CLL Chairs

01:00 PM - 01:15 PM

BTK/BCL2 Resistance in CLL

01:15 PM - 01:30 PM

Noncovalent BTK Inhibitors and Degraders – Nitin Jain, MD

01:30 PM - 01:45 PM

Resistance to BTK Degraders

01:45 PM - 02:00 PM

When do I use CAR T for CLL

02:00 PM - 02:15 PM

Bispecifics in CLL

02:15 PM - 02:25 PM

Case

02:25 PM - 02:45 PM

Case-Based Panel Discussion

Panelist:

Nitin Jain, MD

02:45 PM - 03:00 PMBreak & Exhibits
03:00 PM - 04:45 PMSession 4: Evolution of Treatment for Relapsed/Refractory Lymphoma

03:00 PM - 03:15 PM

First Relapse DLBCL

03:15 PM - 03:30 PM

3rd line + DLBCL – Jason Westin

03:30 PM - 03:45 PM

R/R FL – Caron Jacobson, MD

03:45 PM - 04:00 PM

R/R MCL – Tycel Phillips, MD

04:00 PM - 04:15 PM

R/R HL

04:15 PM - 04:25 PM

Case

04:25 PM - 04:45 PM

Case-Based Panel Discussion

Panelists:

Jason Westin ; Caron Jacobson, MD; Tycel Phillips, MD

04:45 PM - 04:50 PMClosing Remarks and Adjourn

Day 2: Saturday, April 24th, 2027

07:00 AM - 07:55 AMBreakfast, Registration, and Exhibits
07:55 AM - 08:00 AMWelcome & Opening Remarks

Registration and pricing